Profile data is unavailable for this security.
About the company
Procter & Gamble Health Limited is an India-based multinational consumer goods company. The Company is focused on manufacturing and marketing of over-the-counter products, vitamins, minerals, and supplements products for a healthy lifestyle. The Company is engaged in the manufacturing and selling of healthcare products, such as vitamins, minerals and supplements. Patients are end consumers of the products. The Company’s distribution channels (direct and indirect), inter alia, include distributors, health care professionals, pharmacies and chemists. The Company’s brands include Polybion, Cosome, Evion, Neurobion, Seven Seas, Nasivion, and Livogen. Cosome is a medicine which is used to help relieve dry coughs and related congestion symptoms. Evion is a Vitamin E capsules. The Seven Seas is a pure vitamin rich cod-liver oil. Neurobion offers a range of neurotropic supplements. Its products are sold in about 180 countries and territories throughout the world.
- Revenue in INR (TTM)13.49bn
- Net income in INR2.93bn
- Incorporated1967
- Employees1.33k
- LocationProcter & Gamble Health LtdGodrej One,8Th Floor Pirojshanagar, Vikhroli (East)MUMBAI 400099IndiaIND
- Phone+91 2 262109000
- Fax+91 2 262109999
- Websitehttps://www.pghealthindia.com/
More ▼
Peer analysis
Key Information
- Key Information
- Stock Performance
- Per Share Data
- Efficiency
- Management Effectiveness
- Profitability
- Financial Strength
- Growth Rates
| Company | Revenue (TTM) | Net income (TTM) | Market cap | Employees | Price/earnings (TTM) | Price/book value (MRQ) | Price/cash flow (TTM) | Price/sales (TTM) | EPS (excl. extraordinary items, TTM) | EPS (incl. extraordinary items, TTM) | Revenue per share (TTM) | Book value per share (MRQ) | Asset turnover (TTM) | Inventory turnover (TTM) | Receivables turnover (TTM) | Revenues per employee (TTM) | Return on avg assets (TTM) | Return on avg assets (5 yr avg) | Return on investment (TTM) | Return on investment (5 yr avg) | Gross margin (TTM) | Gross margin (5 yr avg) | Net profit margin (TTM) | Net Profit margin (5 yr avg) | Quick ratio (MRQ) | Interest coverage (TTM) | Total debt to capital (MRQ) | Payout ratio (5 yr avg) | Revenue (YOY change %) | Revenue (5 yr growth rate) | Net income (YOY change %) | Net income (5 yr growth rate) | Capital expenditure (5 yr growth rate) | Dividend (5 yr growth rate) |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Supriya Lifescience Ltd | 7.35bn | 1.85bn | 54.80bn | 515.00 | 29.54 | -- | 25.94 | 7.45 | 23.05 | 23.05 | 91.47 | -- | -- | -- | -- | 14,280,700.00 | -- | 18.45 | -- | 21.63 | 72.33 | 59.62 | 25.19 | 25.45 | -- | 129.43 | -- | 3.59 | 22.11 | 17.45 | 57.80 | 20.69 | 45.94 | -- |
| F D C Ltd | 20.78bn | 2.17bn | 61.27bn | 6.86k | 28.27 | -- | 22.11 | 2.95 | 13.31 | 13.31 | 127.73 | -- | -- | -- | -- | 3,030,531.00 | -- | 11.35 | -- | 12.96 | 67.92 | 60.85 | 10.43 | 14.75 | -- | 47.92 | -- | 6.34 | 8.50 | 9.42 | -12.59 | 2.15 | 25.37 | -- |
| Shilpa Medicare Ltd | 14.32bn | 1.50bn | 63.92bn | 898.00 | 42.16 | -- | 23.85 | 4.46 | 7.75 | 7.75 | 73.87 | -- | -- | -- | -- | 15,945,910.00 | -- | 2.02 | -- | 2.61 | 70.47 | 60.07 | 10.48 | 5.17 | -- | 4.67 | -- | 9.89 | 11.71 | 7.22 | 145.63 | -12.90 | 16.09 | -- |
| Aarti Pharmalabs Ltd | 18.01bn | 2.14bn | 64.29bn | 2.16k | 30.08 | -- | 20.56 | 3.57 | 23.58 | 23.58 | 200.27 | -- | -- | -- | -- | 8,324,436.00 | -- | -- | -- | -- | 53.87 | -- | 11.87 | -- | -- | 9.34 | -- | -- | 14.17 | -- | 25.59 | -- | -- | -- |
| Blue Jet Healthcare Ltd | 10.53bn | 2.94bn | 68.92bn | 491.00 | 23.46 | -- | 21.81 | 6.54 | 16.93 | 16.93 | 60.76 | -- | -- | -- | -- | 21,448,020.00 | -- | -- | -- | -- | 53.75 | -- | 27.88 | -- | -- | 59.81 | -- | -- | 44.74 | -- | 86.38 | -- | -- | -- |
| Akums Drugs and Pharmaceuticals Ltd | 41.08bn | 3.17bn | 69.10bn | 7.54k | 21.80 | 2.19 | 14.32 | 1.68 | 20.71 | 20.71 | 268.25 | 205.66 | 0.8712 | 3.69 | 4.85 | 5,450,531.00 | 6.86 | -- | 8.82 | -- | 41.18 | -- | 7.87 | -- | 3.18 | 4.98 | 0.0277 | -- | -1.44 | -- | 8,481.07 | -- | -- | -- |
| Sudeep Pharma Ltd | 6.17bn | 1.68bn | 75.49bn | -- | 43.85 | -- | 41.10 | 12.24 | 15.24 | 15.24 | 55.94 | -- | -- | -- | -- | -- | -- | -- | -- | -- | 63.01 | -- | 27.56 | -- | -- | 55.99 | -- | -- | 9.40 | -- | 4.19 | -- | -- | -- |
| Strides Pharma Science Ltd | 47.26bn | 5.11bn | 79.05bn | 3.30k | 15.46 | -- | 10.86 | 1.67 | 55.49 | 55.49 | 512.73 | -- | -- | -- | -- | 14,315,680.00 | -- | -0.6014 | -- | -1.09 | 59.34 | 50.33 | 11.23 | -1.06 | -- | 8.50 | -- | -- | 17.36 | 10.65 | 437.22 | 52.50 | 10.08 | -22.16 |
| Marksans Pharma Ltd | 28.03bn | 3.60bn | 82.36bn | 1.35k | 22.84 | -- | 17.95 | 2.94 | 7.96 | 7.96 | 61.92 | -- | -- | -- | -- | 20,780,450.00 | -- | 14.15 | -- | 17.41 | 56.77 | 51.56 | 12.90 | 14.58 | -- | 20.42 | -- | 7.77 | 20.46 | 18.25 | 21.32 | 26.60 | 23.73 | 51.57 |
| Procter & Gamble Health Ltd | 13.49bn | 2.93bn | 82.81bn | 1.33k | 28.24 | -- | 26.18 | 6.14 | 176.64 | 176.64 | 811.45 | -- | -- | -- | -- | 10,169,760.00 | -- | -- | -- | -- | 72.49 | -- | 21.76 | -- | -- | 806.81 | -- | -- | -- | -- | -- | -- | -- | -- |
| Jeena Sikho Lifecare Ltd | -100.00bn | -100.00bn | 86.81bn | 3.76k | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | 32.29 | -- | 40.74 | -- | 92.07 | -- | 16.78 | -- | -- | -- | -- | 44.59 | 37.80 | 31.10 | 73.77 | 47.62 | -- |
| Sanofi India Ltd | 19.33bn | 3.56bn | 92.97bn | 991.00 | 26.09 | -- | 23.61 | 4.81 | 154.71 | 154.71 | 839.09 | -- | -- | -- | -- | 19,500,500.00 | -- | 22.31 | -- | 31.44 | 51.42 | 54.10 | 18.44 | 21.53 | -- | 321.27 | -- | 132.73 | 0.8567 | -8.10 | -13.96 | -5.41 | -13.65 | 1.99 |
| Viyash Scientific Ltd | 21.26bn | 768.08m | 94.36bn | 1.24k | 91.13 | -- | 46.88 | 4.44 | 2.37 | 2.37 | 70.40 | -- | -- | -- | -- | 17,086,170.00 | -- | 0.4014 | -- | 0.6553 | 51.15 | 42.16 | 4.52 | 0.4199 | -- | 3.92 | -- | 995.91 | 13.26 | 5.64 | 160.99 | -20.73 | -0.126 | -- |
| Corona Remedies Ltd | 13.44bn | 1.71bn | 97.43bn | 4.57k | 56.87 | -- | 46.63 | 7.25 | 28.01 | 28.01 | 219.70 | -- | -- | -- | -- | 2,980,876.00 | -- | -- | -- | -- | 81.28 | -- | 12.75 | -- | -- | 55.10 | -- | -- | 17.93 | -- | 65.11 | -- | -- | -- |
| Sanofi Consumer Healthcare India Ltd | 8.16bn | 2.18bn | 98.81bn | 583.00 | 45.35 | -- | 43.49 | 12.10 | 94.62 | 94.62 | 354.49 | -- | -- | -- | -- | 14,003,430.00 | -- | -- | -- | -- | 75.05 | -- | 26.69 | -- | -- | 143.16 | -- | -- | 30.45 | -- | 9.76 | -- | -- | -- |
| Alivus Life Sciences Ltd | 25.12bn | 5.44bn | 112.89bn | 2.20k | 20.80 | -- | 18.36 | 4.49 | 44.23 | 44.23 | 204.37 | -- | -- | -- | -- | 11,403,810.00 | -- | 17.43 | -- | 23.95 | 57.08 | 53.29 | 21.64 | 20.24 | -- | 133.39 | -- | 27.09 | 4.54 | 9.20 | 3.13 | 9.18 | 26.57 | -- |
Data as of Feb 16 2026. Currency figures normalised to Procter & Gamble Health Ltd's reporting currency: Indian Rupee INR
15.93%Per cent of shares held by top holders
| Holder | Shares | % Held |
|---|---|---|
| Nippon Life India Asset Management Ltd. (Invt Mgmt)as of 31 Dec 2025 | 692.66k | 4.17% |
| ICICI Prudential Asset Management Co. Ltd. (Invt Mgmt)as of 31 Jan 2026 | 410.70k | 2.47% |
| Life Insurance Corporation of India (Investment Portfolio)as of 30 Jun 2025 | 316.61k | 1.91% |
| The Vanguard Group, Inc.as of 04 Feb 2026 | 312.64k | 1.88% |
| UTI Asset Management Co. Ltd. (Investment Management)as of 31 Jan 2026 | 304.83k | 1.84% |
| DSP Asset Managers Pvt. Ltd.as of 31 Jan 2026 | 159.29k | 0.96% |
| Dimensional Fund Advisors LPas of 05 Feb 2026 | 138.64k | 0.84% |
| BlackRock Fund Advisorsas of 06 Feb 2026 | 134.38k | 0.81% |
| Aditya Birla Sun Life Amc Ltd. (Investment Management)as of 31 Jan 2026 | 88.72k | 0.53% |
| Norges Bank Investment Managementas of 30 Jun 2025 | 85.13k | 0.51% |
More ▼
Data from 31 Dec 2025 - 10 Feb 2026Source: FactSet Research Systems Inc.
